PlainRecalls
FDA Drug Moderate Class II Terminated

Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15

Reported: May 6, 2020 Initiated: April 15, 2020 #D-1253-2020

Product Description

Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15

Reason for Recall

CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Details

Units Affected
11258 bottles
Distribution
Nationwide
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 11258 bottles.
Why was this product recalled?
CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 6, 2020. Severity: Moderate. Recall number: D-1253-2020.